A detailed history of Goldman Sachs Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,059,361 shares of NVS stock, worth $316 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,059,361
Previous 3,535,902 13.48%
Holding current value
$316 Million
Previous $357 Million 17.11%
% of portfolio
0.05%
Previous 0.07%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $45.4 Million - $51.7 Million
-476,541 Reduced 13.48%
3,059,361 $296 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $70.3 Million - $77.3 Million
761,545 Added 27.45%
3,535,902 $357 Million
Q3 2023

May 14, 2024

SELL
$94.73 - $105.13 $72.1 Million - $80.1 Million
-761,545 Reduced 21.54%
2,774,357 $283 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $11.7 Million - $12.9 Million
-123,107 Reduced 4.25%
2,774,357 $283 Million
Q2 2023

May 14, 2024

SELL
$92.52 - $104.91 $162 Million - $183 Million
-1,747,915 Reduced 37.63%
2,897,464 $292 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $162 Million - $183 Million
-1,747,915 Reduced 37.63%
2,897,464 $292 Million
Q1 2023

May 14, 2024

BUY
$80.03 - $92.81 $222 Million - $257 Million
2,768,876 Added 147.56%
4,645,379 $427 Million
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $222 Million - $257 Million
2,768,876 Added 147.56%
4,645,379 $427 Million
Q4 2022

May 14, 2024

SELL
$75.55 - $92.52 $61.1 Million - $74.8 Million
-808,960 Reduced 30.12%
1,876,503 $170 Million
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $61.1 Million - $74.8 Million
-808,960 Reduced 30.12%
1,876,503 $170 Million
Q3 2022

May 14, 2024

BUY
$74.61 - $87.26 $3.74 Million - $4.37 Million
50,131 Added 1.9%
2,685,463 $204 Million
Q3 2022

Nov 10, 2022

BUY
$74.61 - $87.26 $3.74 Million - $4.37 Million
50,131 Added 1.9%
2,685,463 $204 Million
Q2 2022

May 14, 2024

SELL
$80.52 - $93.75 $72.5 Million - $84.4 Million
-900,570 Reduced 25.47%
2,635,332 $223 Million
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $11.8 Million - $13.7 Million
-146,264 Reduced 5.26%
2,635,332 $223 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $47.6 Million - $53.8 Million
594,194 Added 27.16%
2,781,596 $244 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $8.68 Million - $9.6 Million
108,936 Added 5.24%
2,187,402 $191 Million
Q3 2021

Nov 10, 2021

BUY
$81.78 - $95.14 $170 Million - $198 Million
2,078,466 New
2,078,466 $170 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.